期刊文献+

三大高血压指南精要对比解读 被引量:8

Comparative Interpretation of Hypertension Guidelines
下载PDF
导出
摘要 本文对2009版欧洲高血压协会/欧洲心脏病学会(ESH/ESC)高血压指南再评价、2010版中国高血压防治指南和2011版英国国家健康与临床医疗研究所(NICE)指南中的要点进行了对比解读,强调总体心血管风险评估以及个体化设定降压目标的重要性,指出五大类降压药均可作为高血压的起始和维持用药,强调我国的临床实践应以我国现行的高血压防治指南为准。 Objective After carefully reappraisal of European guidelines on hypertension management and comparative interpretation of essentials and highlights of 2010 Chinese guidelines and those of 2011 National Institute for Health and Clinical Excellence(NICE),the paper was put much emphasis on the importance of overall cardiovascular risk assessment and individualized pressure goal,pointing out all of the five classes of antihypertensive agents can be used to initiate and sustain antihypertensive treatment,the prevention and treatment of hypertension in China should be based on Chinese current guidelines.
作者 王勇 范书英
出处 《中国全科医学》 CAS CSCD 北大核心 2012年第11期1185-1188,共4页 Chinese General Practice
关键词 高血压 指南 药物疗法 联合 Hypertension Guidebooks Drug therapy combination
  • 相关文献

参考文献7

  • 1王文,张宇清,张学中,张善同,唐新华,陈涛,周景春,张亮清,张廷杰,孙明,王云献,齐德仁,王宪衍,刘力生.高血压患者治疗后平均血压水平与心脑血管事件的关系--非洛地平降低并发症研究分析[J].中华高血压杂志,2010,18(5):439-443. 被引量:28
  • 2PATS Collaborating Group.POST-STROKE ANTIHYPERTENSIVE TREATMENT STUDY A PRELIMINARY RESULT[J].Chinese Medical Journal,1995(9):72-79. 被引量:98
  • 3.Reappraisal of European guidelines on hypertension management:a Eu-ropean Society of Hypertension Task Force document[].ht-tp://wwwishorgil/GuidelinesESHpdf.
  • 4National Institute for Health and Clinical Excellence.Hypertension:theclinical management of primary hypertension in adults[].ht-tp://wwwniceorguk/nicemedia/live///pdf.
  • 5Wang X,Qin X,Demirtas H,et al.Efficacy of folic acid supplemen-tation in stroke prevention:a meta-analysis[].The Lancet.2007
  • 6Liu L,Zhang Y,Liu G,et al.The felodipine event reduction (FLVER)study:a randomized long-term placebo-controlled trialin Chinese hypertensive patients[].Journal of Hypertension.2005
  • 7Arima H,Anderson C,Omae T,et al.Perindopril-based bloodpressure lowering reduces major vascular events in Asian and Westernparticipants with cerebrovascular disease:the PROGRESS trial[].Journal of Hypertension.2010

二级参考文献19

  • 1王文,邓卿,王宪衍,马丽媛,路方红,崔家玉,张放,周宏研,张鹏强,张亮清,王守富,张路毅,林金秀,郑志荣,黄萍,金翠燕,施东伟,王剑英,李丽,郄曙光,舒聃,龚辉,吕家珍,张华茹,饶萍,袁光雷,王卫国,曹东平,方渭清,龚兰生,刘力生,降压治疗预防脑卒中研究协作组.6年降压治疗对脑血管病患者脑卒中再发事件的预防效果[J].中华高血压杂志,2007,15(4):281-284. 被引量:13
  • 2卫生部心血管病防治研究中心.中国心血管病报告-2007[M].北京:中国大百科全书出版社,2008:1-10.
  • 3Liu LS, Zhang YQ, Liu GZ, etal. For the FEVER Study Group. The felodipine event reduction (FEVER) study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients [J]. J Hypertens,2005,23(12) :2157-2172.
  • 4Samuelsson OG, Wilhelmsen LW, Pennert KM, et al. The J- shaped relationship between coronary heart disease and achieved blood pressure level in treated hypertension: further analyses of 12 years of follow-up of treated hypertensives in the primary prevention trial in gothenburg, sweden[J]. J Hypertens, 1990,8(6) : 547- 555.
  • 5Yusuf S, Diener HC, Sacco RL, et al. For PROFESS Study Group. Telmisartan to prevent recurrent stroke and cardiovascular events[J]. N Engl J Med, 2008,359 (12) : 1225-1237.
  • 6Lawes CM, Rodgers A, Bennett DA, et al. For asia pacific cohort studies collaboration. Blood pressure and cardiovascular diseases in the Asia-Pacific region[J]. J Hypertens, 2003,21 (4) : 707-716.
  • 7Lewington S, Clarke R, Qizilbash N, et al. For prospective studies collaboration. Age-specific relevanee of usual blood pressure to vascular mortality., a meta-analysis of individual data for one million adults in 61 prospective studies[J]. Lancet, 2002,360(9349): 1903-1913.
  • 8Arima H, Chalmers J, Woodward M, et al. For the PROGRESS Collaborative Group. Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial [J]. J Hypertens,2006,24(6) : 1201-1208.
  • 9Arima H, Anderson C, Omae T. For the PROGRESS Collaborative Group. Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial[J]. J Hypertens, 2010,28 (2) :395-400.
  • 10Zanchetti A, Mancia G, Black HR, et al. Facts and fallacies of blood pressure control in recent trials:implications in the management of patients with hypertension[J]. J. Hypertens, 2009,27 (4) : 673-679.

共引文献117

同被引文献78

引证文献8

二级引证文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部